• The Orion spatial proteomics platform reproducibly delivers the biomarker depth at a capacity demanded by clinical trials for precision therapies
• Discover how this groundbreaking technology redefines how spatial biology is used for clinical trials
TAD GEORGE, Senior Vice President R&D, Rarecyte
